posted on 2023-06-12, 12:03authored byYen T.
H. Lam, Jana Hoppe, Quang N. Dang, Andrea Porzel, Alena Soboleva, Wolfgang Brandt, Robert Rennert, Hidayat Hussain, Mehdi D. Davari, Ludger Wessjohann, Norbert Arnold
Three previously undescribed azepino-indole alkaloids,
named purpurascenines
A–C (1–3), together with the
new-to-nature 7-hydroxytryptophan (4) as well as two
known compounds, adenosine (5) and riboflavin (6), were isolated from fruiting bodies of Cortinarius
purpurascens Fr. (Cortinariaceae). The structures of 1–3 were elucidated based on spectroscopic
analyses and ECD calculations. Furthermore, the biosynthesis of purpurascenine
A (1) was investigated by in vivo experiments
using 13C-labeled sodium pyruvate, alanine, and sodium
acetate incubated with fruiting bodies of C. purpurascens. The incorporation of 13C into 1 was analyzed
using 1D NMR and HRESIMS methods. With [3-13C]-pyruvate,
a dramatic enrichment of 13C was observed, and hence a
biosynthetic route via a direct Pictet–Spengler reaction between
α-keto acids and 7-hydroxytryptophan (4) is suggested
for the biosynthesis of purpurascenines A–C (1–3). Compound 1 exhibits no antiproliferative
or cytotoxic effects against human prostate (PC-3), colorectal (HCT-116),
and breast (MCF-7) cancer cells. An in silico docking
study confirmed the hypothesis that purpurascenine A (1) could bind to the 5-HT2A serotonin receptor’s
active site. A new functional 5-HT2A receptor activation
assay showed no functional agonistic but some antagonistic effects
of 1 against the 5-HT-dependent 5-HT2A activation
and likely antagonistic effects on putative constitutive activity
of the 5-HT2A receptor.